113 related articles for article (PubMed ID: 22764774)
1. Mending a growth-restricted fetal heart: should we use glucocorticoids?
Hodges RJ; Wallace EM
J Matern Fetal Neonatal Med; 2012 Nov; 25(11):2149-53. PubMed ID: 22764774
[TBL] [Abstract][Full Text] [Related]
2. Antenatal glucocorticoids reduce growth in appropriately grown and growth-restricted ovine fetuses in a sex-specific manner.
Miller SL; Sutherland AE; Supramaniam VG; Walker DW; Jenkin G; Wallace EM
Reprod Fertil Dev; 2012; 24(5):753-8. PubMed ID: 22697125
[TBL] [Abstract][Full Text] [Related]
3. Antenatal glucocorticoid treatment of the growth-restricted fetus: benefit or cost?
Morrison JL; Orgeig S
Reprod Sci; 2009 Jun; 16(6):527-38. PubMed ID: 19276405
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular responses to maternal betamethasone administration in the intrauterine growth-restricted ovine fetus.
Miller SL; Supramaniam VG; Jenkin G; Walker DW; Wallace EM
Am J Obstet Gynecol; 2009 Dec; 201(6):613.e1-8. PubMed ID: 19766978
[TBL] [Abstract][Full Text] [Related]
5. Antenatal steroids and the IUGR fetus: are exposure and physiological effects on the lung and cardiovascular system the same as in normally grown fetuses?
Morrison JL; Botting KJ; Soo PS; McGillick EV; Hiscock J; Zhang S; McMillen IC; Orgeig S
J Pregnancy; 2012; 2012():839656. PubMed ID: 23227338
[TBL] [Abstract][Full Text] [Related]
6. Gene expression patterns of the 11β-hydroxysteroid dehydrogenase 2 enzyme in human placenta from intrauterine growth restriction: the role of impaired feto-maternal glucocorticoid metabolism.
Börzsönyi B; Demendi C; Pajor A; Rigó J; Marosi K; Agota A; Nagy ZB; Joó JG
Eur J Obstet Gynecol Reprod Biol; 2012 Mar; 161(1):12-7. PubMed ID: 22239940
[TBL] [Abstract][Full Text] [Related]
7. [Lung maturation therapy with glucocorticoids in threatened premature labor. Considerations of risk-benefit in evidence-based medicine].
Sauerwald A; Rath W
Z Geburtshilfe Neonatol; 2000; 204(6):203-9. PubMed ID: 11199148
[TBL] [Abstract][Full Text] [Related]
8. Ruminant models of prenatal growth restriction.
Anthony RV; Scheaffer AN; Wright CD; Regnault TR
Reprod Suppl; 2003; 61():183-94. PubMed ID: 14635935
[TBL] [Abstract][Full Text] [Related]
9. [Intrauterine growth retardation--perinatal mortality and postnatal morbidity in a perinatal center].
Meyberg R; Boos R; Babajan A; Ertan AK; Schmidt W
Z Geburtshilfe Neonatol; 2000; 204(6):218-23. PubMed ID: 11199150
[TBL] [Abstract][Full Text] [Related]
10. Intrauterine growth restriction--diagnosis and management.
Sheridan C
Aust Fam Physician; 2005 Sep; 34(9):717-23. PubMed ID: 16184202
[TBL] [Abstract][Full Text] [Related]
11. Enhancing functional maturity before preterm birth.
Hallman M; Peltoniemi O; Kari MA
Neonatology; 2010 Jun; 97(4):373-8. PubMed ID: 20551706
[TBL] [Abstract][Full Text] [Related]
12. [Limit of antenatal management of intrauterine growth retarded fetus].
Takagi K
Nihon Sanka Fujinka Gakkai Zasshi; 1993 Aug; 45(8):808-14. PubMed ID: 7690387
[TBL] [Abstract][Full Text] [Related]
13. The effects of intrauterine growth restriction and antenatal glucocorticoids on ovine fetal lung development.
Sutherland AE; Crossley KJ; Allison BJ; Jenkin G; Wallace EM; Miller SL
Pediatr Res; 2012 Jun; 71(6):689-96. PubMed ID: 22337223
[TBL] [Abstract][Full Text] [Related]
14. Maternal and fetal cord blood lipids in intrauterine growth restriction.
Pecks U; Brieger M; Schiessl B; Bauerschlag DO; Piroth D; Bruno B; Fitzner C; Orlikowsky T; Maass N; Rath W
J Perinat Med; 2012 Jan; 40(3):287-96. PubMed ID: 22505508
[TBL] [Abstract][Full Text] [Related]
15. Dexamethasone-induced intrauterine growth restriction impacts the placental prolactin family, insulin-like growth factor-II and the Akt signaling pathway.
Ain R; Canham LN; Soares MJ
J Endocrinol; 2005 May; 185(2):253-63. PubMed ID: 15845918
[TBL] [Abstract][Full Text] [Related]
16. Renal effects of antenatally or postnatally administered steroids.
Cattarelli D; Chirico G; Simeoni U
Pediatr Med Chir; 2002; 24(2):157-62. PubMed ID: 11987524
[TBL] [Abstract][Full Text] [Related]
17. The Story of Antenatal Steroid Therapy before Preterm Birth.
Hallman M
Neonatology; 2015; 107(4):352-7. PubMed ID: 26044103
[TBL] [Abstract][Full Text] [Related]
18. Maternal melatonin administration mitigates coronary stiffness and endothelial dysfunction, and improves heart resilience to insult in growth restricted lambs.
Tare M; Parkington HC; Wallace EM; Sutherland AE; Lim R; Yawno T; Coleman HA; Jenkin G; Miller SL
J Physiol; 2014 Jun; 592(12):2695-709. PubMed ID: 24710061
[TBL] [Abstract][Full Text] [Related]
19. Nonlinear analyses of heart rate variability in normal and growth-restricted fetuses.
Kikuchi A; Shimizu T; Hayashi A; Horikoshi T; Unno N; Kozuma S; Taketani Y
Early Hum Dev; 2006 Apr; 82(4):217-26. PubMed ID: 16242867
[TBL] [Abstract][Full Text] [Related]
20. Potential risks and benefits of antenatal corticosteroid therapy prior to preterm birth in pregnancies complicated by severe fetal growth restriction.
Vidaeff AC; Blackwell SC
Obstet Gynecol Clin North Am; 2011 Jun; 38(2):205-14, ix. PubMed ID: 21575796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
